Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Sanitization of Chromatography Columns – V 2.0

Posted on By


Biosimilars: SOP for Sanitization of Chromatography Columns – V 2.0


Standard Operating Procedure for Sanitization of Chromatography Columns in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/166/2025
Supersedes SOP/BS/166/2022
Page No. Page 1 of 9
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for sanitizing chromatography columns used in the purification of biosimilar proteins to prevent microbial contamination, ensure resin longevity, and maintain GMP compliance.

2. Scope

This SOP applies to all chromatography columns (pre-packed or manually packed) used in downstream processing, including ion-exchange, hydrophobic interaction, affinity, and size exclusion chromatography systems.

3. Responsibilities

  • Production: Perform sanitization using approved reagents and ensure completion of all steps as per protocol.
  • QA: Review sanitization records, chemical usage logs, and approve column for subsequent runs.
  • Engineering: Maintain cleaning skids and pumps used during sanitization procedures.

4. Accountability

The Downstream Production Manager is accountable for proper sanitization, execution documentation, and ensuring cleaning verification is completed.

5. Procedure

5.1 Preparation

  1. Ensure the column is properly connected to a validated cleaning-in-place (CIP) skid or chromatography system.
  2. Verify that all hoses and seals are intact and leak-free.
  3. Prepare the sanitizing agent as per validated concentration (e.g., 0.5 M NaOH, 0.1 M NaOH, or 2% NaOCl).
  4. Confirm availability of WFI for rinsing and storage buffer for column preservation.

5.2 Sanitization Process

  1. Flush the column with WFI for 1–2 column volumes (CV) to remove residual product or buffers.
  2. Introduce sanitizing agent at a flow rate of 50–100 cm/hr.
  3. Allow static contact for minimum 30 minutes to achieve bioburden reduction.
  4. Recirculate sanitizing agent if specified by resin manufacturer (e.g., 3 cycles).

5.3 Post-Sanitization Rinsing

  1. Flush column with WFI until pH of effluent matches that of WFI (typically 6.0–7.0).
  2. Monitor conductivity to ensure removal of sanitizing agent (target < 10 µS/cm).
  3. Document number of rinse cycles and volume used in Annexure-1.

5.4 Storage

  1. If the column is not immediately reused, flush with storage buffer (e.g., 20% ethanol in WFI).
  2. Seal both ends with sanitary plugs and label with date of sanitization and next due date.
  3. Store horizontally (for large columns) or as per resin manufacturer’s recommendation.

5.5 Cleaning Verification

  1. Conduct rinse sampling for TOC (Total Organic Carbon) and residual NaOH verification.
  2. Ensure all acceptance criteria are met before releasing column for production use.
  3. Record verification data in Annexure-2.

6. Abbreviations

  • CIP: Clean-In-Place
  • WFI: Water for Injection
  • TOC: Total Organic Carbon
  • CV: Column Volume

7. Documents

  1. Sanitization Record – Annexure-1
  2. Cleaning Verification Report – Annexure-2

8. References

  • ICH Q9 – Quality Risk Management
  • WHO TRS 999 – GMP Guidelines for Biotherapeutics
  • OEM Resin Cleaning Guidelines (GE/Cytiva, Repligen, Bio-Rad)

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Sanitization Record

Date Column ID Sanitizing Agent Contact Time Rinse Cycles Operator
04/05/2025 COL-HIC-104 0.5 M NaOH 30 min 3 Ajay Verma

Annexure-2: Cleaning Verification Report

Parameter Limit Result Pass/Fail Verified By
pH of final rinse 6.0–7.5 6.8 Pass Sunita Reddy
Conductivity < 10 µS/cm 6.2 µS/cm Pass Sunita Reddy
TOC < 500 ppb 410 ppb Pass Sunita Reddy

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Included TOC and conductivity verification for final rinse QA audit recommendation
See also  Biosimilars: SOP for Transformation and Electroporation - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Incomplete Training Records: A Critical Compliance Gap in GMP Environments
Next Post: Language Considerations in Global SOP Writing

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version